Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Pharming Group Q3 Prel. Revenue Rises; Tightens FY26 Revenue Guidance

(RTTNews) - Pharming Group N.V. (PHGUF.PK, PHGUF.OB, PHAR, PHARM.AS), a Netherlands-based biotechnology company focused on rare immune and genetic diseases, on Thursday reported increased preliminary revenue for the third quarter of fiscal 2026, driven by higher revenue from its

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Thursday 22 October →